Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Howard Lapsley

Partner, Health & Life Sciences, Oliver Wyman

From Walmart to Amazon to 23andMe, these 11 market scenarios paint a picture of what disruption looks like, both in and out of healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Chief Strategy Officer, BCBS of Massachusetts
Principal, Health & Life Sciences, Oliver Wyman

Digital distribution industry leaders face a tipping point. Here's how to stay ahead of healthcare’s ongoing disruption.

Chief Product Officer and Co-Founder, Maxwell Health
Partner, Health & Life Sciences, Oliver Wyman

Tomorrow’s healthcare consumer still wants a personalized experience – like that of Apple and Netflix. Here’s how the industry can bridge that gap.

Partner, Health & Life Sciences, Oliver Wyman
Chief Client and Strategy Officer, Lippincott

In the face of today’s market turmoil and revenue insecurity, ancillary products offer a stable, growing profit pool for health plans.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

New political climate positions private exchanges for take-off. Learn why.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

What does the future hold for brokers? Fast track to dustbin of history or cemented place in new marketplace?

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Private exchanges are here to stay, say Oliver Wyman’s Chris Bernene and Howard Lapsley. Five reasons why payers should double down on private exchange strategy.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

With their strategic control of data and money flow, payers have an opportunity to be the connective tissue for the new healthcare ecosystem.

Partner, Health & Life Sciences, Oliver Wyman

Earlier this week, on the same day, Gap announced it was closing 175 or 25% of its retail stores, while CVS Health proclaimed it was purchasing Target’s pharmacy and clinic business for $1.9 billion as part of an aggressive expansion push.

Partner, Health & Life Sciences, Oliver Wyman

Traditionally, visits to retail clinics were almost an entirely out-of-pocket expense. Now, as Forbes reports, retailers like CVS, Walgreens, and Wal-Mart are finding that the majority of their clinics’ visits are covered by insurance. Oliver Wyman’s Howard Lapsley puts this milestone into perspective.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe